Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.31.1 (
micrococcal nuclease
)
2,818
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
PP1 (protein phosphatase-1) is a serine/threonine phosphatase involved in mitosis exit and chromosome decondensation. In the present study, we characterize the subcellular and subnuclear localization of
PNUTS
(PP1 nuclear targeting subunit), a nuclear regulatory subunit of PP1, and report a stimulatory role of
PNUTS
in the decondensation of prometaphase chromosomes in two in vitro systems. In interphase,
PNUTS
co-fractionates, together with a fraction of nuclear PP1, primarily with
micrococcal nuclease
-soluble chromatin. Immunofluorescence analysis shows that
PNUTS
is targeted to the reforming nuclei in telophase following the assembly of nuclear membranes and concomitantly with chromatin decondensation. In interphase cytosolic extract, ATP-dependent decondensation of prometaphase chromosomes is blocked by PP1-specific inhibitors. In contrast, a recombinant
PNUTS
(309-691) fragment accelerates chromosome decondensation. This decondensation-promoting activity requires the consensus RVXF PP1-binding motif of
PNUTS
, whereas a secondary, inhibitory PP1-binding site is dispensable. In a defined buffer system,
PNUTS
(309-691) also elicits decondensation in an exogenous PP1-dependent manner and, as in the cytosolic extract, a W401A (Thr401-->Ala) mutation that destroys PP1 binding abolishes this activity. The results illustrate an involvement of the
PNUTS
:PP1 holoenzyme in chromosome decondensation in vitro and argue that
PNUTS
functions as a PP1-targeting subunit in this process. We hypothesize that targeting of
PNUTS
to reforming nuclei in telophase may be a part of a signalling event promoting chromatin decondensation as cells re-enter interphase.
...
PMID:PNUTS enhances in vitro chromosome decondensation in a PP1-dependent manner. 1590 95